Evidence map›Paper›PMID 42287381›Full record

ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026

Non-tobacco nicotine use and complications in single-level posterior lumbar and transforaminal lumbar interbody fusion.

Alexander Nguyen, Rigel Hall, Ryan Lebens, Vishal Harnoor, Zach Pennington, Brandon Lucke-Wold, Benjamin Elder

Abstract read
PubMed Publisher
In one paragraph

Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander NguyenCreighton University School of Medicine, Phoenix, AZ, USA. alexandernguyen@creighton.edu.
Rigel HallCreighton University School of Medicine, Phoenix, AZ, USA.
Ryan LebensRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA.
Vishal HarnoorCreighton University School of Medicine, Phoenix, AZ, USA.
Zach PenningtonDepartment of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
Brandon Lucke-WoldDepartment of Neurosurgery, University of Florida College of Medicine, Gainesville, FL, USA.
Benjamin ElderDepartment of Neurosurgery, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOver 300,000 lumbar fusion surgeries are performed annually for various indications. Tobacco use has previously been demonstrated to increase rates of nonunion and mechanical complications, but the impact of non-tobacco nicotine (NTN) products is less well known. Given the increasing NTN use, the present study aimed to explore their effect on postoperative outcomes following single-level posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) procedures.

methodsThe TriNetX database was retrospectively reviewed using Current Procedural Terminology (CPT) codes to identify all patients who underwent single-level PLIF or TLIF. Patients were excluded if they underwent multilevel PLIFs/TLIFs, concomitant or adjunct anterior fusion, or underwent surgery for infection, fracture, tumor, or deformity. Patients were stratified into cohorts based on preoperative NTN use, excluding those with tobacco use or dependence determined by International Classification of Disease (ICD)-10 codes. 1:1 propensity score matching was performed using age at surgery, sex, BMI, anticoagulant use, and Charlson Comorbidity Index. Outcomes of interest were 90-day medical complications (including venous thromboembolism, wound infection, dysphagia) and two-year primary implant-related complications (e.g., pseudarthrosis, adjacent segment disease, hardware failure).

results43,683 patients were identified (3,879 and 39,804 patients for NTN and control), which produced cohorts of 3,523 patients each after propensity matching. NTN patients had significantly higher odds of emergency department (ED) visits and opioid abuse/dependence at 90-days (9.3% vs. 7.2%; p = 0.001), (0.9% vs. 0.5%; p = 0.038) and 2-years (21.9% vs. 16.7%; p < 0.001), (2.7% vs. 1.1%, p < 0.001) respectively. Groups did not differ in the rates of any studied medical complication, including infection (2.3% vs. 2.2%; p = 0.69), or dysphagia (0.4% vs. 0.4%; p = 0.70). At 2 years postoperative, NTN patients had significantly higher odds of pseudarthrosis (22.2% vs. 14.1%; p < 0.001) and adjacent segment degeneration (ASD) (10.6% vs. 7.5%; p < 0.001). There was no significant difference in implant failure (0.8% vs. 0.7%; p = 0.67).

conclusionThe present analysis finds NTN use to be associated with increased rates of ED visits, opioid dependence, pseudarthrosis, and ASD following single-level PLIF/TLIF. The results suggest NTN may negatively impact fusion outcomes in a manner similar to conventional tobacco products.

Indexed as

ComplicationLumbar spinal fusionNeurosurgeryNon-Tobacco NicotineOrthopedic surgeryRisk

Identifiers

PMID42287381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.